10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2021 | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 9, 2022) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Cash Flows From Operating Activities: | |||
| Net Earnings/(Loss) | $ 7,014 | (8,995) | 3,460 |
| Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities: | |||
| Depreciation and amortization, net | 10,686 | 10,380 | 1,746 |
| Deferred income taxes | (1,393) | 983 | (924) |
| Stock-based compensation | 583 | 779 | 441 |
| Impairment charges | 1,207 | 1,203 | 199 |
| Pension settlements and amortization | 35 | 43 | 1,688 |
| Divestiture gains and royalties | (684) | (699) | (1,855) |
| IPRD charge - MyoKardia acquisition | 0 | 11,438 | 0 |
| Asset acquisition charges | 1,157 | 1,099 | 63 |
| Equity investment gains, net | (745) | (1,228) | (275) |
| Contingent consideration fair value adjustments | (542) | (1,757) | 523 |
| Other adjustments | 142 | (177) | (26) |
| Changes in operating assets and liabilities: | |||
| Receivables | (1,054) | (646) | 752 |
| Inventories | 13 | 2,672 | 463 |
| Accounts payable | 245 | 188 | 229 |
| Rebates and discounts | 863 | 1,189 | 591 |
| Income taxes payable | (1,063) | (2,305) | 907 |
| Other | (257) | (115) | 228 |
| Net Cash Provided by Operating Activities | 16,207 | 14,052 | 8,210 |
| Cash Flows From Investing Activities: | |||
| Sale and maturities of marketable debt securities | 4,196 | 6,280 | 3,809 |
| Purchase of marketable debt securities | (5,478) | (4,172) | (3,961) |
| Proceeds from sales of equity investment securities | 2,579 | 129 | 167 |
| Capital expenditures | (973) | (753) | (836) |
| Divestiture and other proceeds | 748 | 741 | 15,685 |
| Acquisition and other payments, net of cash acquired | (1,610) | (13,084) | (24,777) |
| Net Cash Used in Investing Activities | (538) | (10,859) | (9,913) |
| Cash Flows From Financing Activities: | |||
| Short-term debt obligations, net | (160) | (267) | 131 |
| Issuance of long-term debt | 0 | 6,945 | 26,778 |
| Repayment of long-term debt | (6,022) | (2,750) | (9,256) |
| Repurchase of common stock | (6,287) | (1,546) | (7,300) |
| Dividends | (4,396) | (4,075) | (2,679) |
| Other | 641 | 542 | (53) |
| Net Cash (Used in)/Provided by Financing Activities | (16,224) | (1,151) | 7,621 |
| Effect of Exchange Rates on Cash, Cash Equivalents and Restricted Cash | (102) | 111 | (9) |
| Increase in Cash, Cash Equivalents and Restricted Cash | (657) | 2,153 | 5,909 |
| Cash, Cash Equivalents and Restricted Cash at Beginning of Year | 14,973 | 12,820 | |
| Cash, Cash Equivalents and Restricted Cash at End of Year | 14,316 | 14,973 | 12,820 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |